<?xml version='1.0' encoding='utf-8'?>
<document id="31369085"><sentence text="Cushing's syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database."><entity charOffset="46-55" id="DDI-PubMed.31369085.s1.e0" text="ritonavir" /><entity charOffset="74-89" id="DDI-PubMed.31369085.s1.e1" text="corticosteroids" /><pair ddi="false" e1="DDI-PubMed.31369085.s1.e0" e2="DDI-PubMed.31369085.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31369085.s1.e0" e2="DDI-PubMed.31369085.s1.e1" /></sentence><sentence text="To explore the frequent interaction between antiretroviral-boosting agents and corticosteroids causing Cushing's syndrome (CS) in the French Pharmacovigilance Database (FPVD)"><entity charOffset="79-94" id="DDI-PubMed.31369085.s2.e0" text="corticosteroids" /></sentence><sentence text="" /><sentence text="We conducted a retrospective case-control study describing CS recorded in the FPVD between 1996 and 2018" /><sentence text=" Case was defined as CS occurring in people living with HIV (PLWH) and control was defined as CS in uninfected individuals" /><sentence text=" Drug-drug interaction (DDI) was defined as an interaction between corticosteroids and CYP3A4 inhibitors"><entity charOffset="67-82" id="DDI-PubMed.31369085.s6.e0" text="corticosteroids" /></sentence><sentence text=" Data concerning the DDI, corticosteroids involved, route of administration and seriousness of the CS were described"><entity charOffset="26-41" id="DDI-PubMed.31369085.s7.e0" text="corticosteroids" /></sentence><sentence text="" /><sentence text="Among the 139 instances of CS identified, 34/35 cases (97%) had DDIs (31 with ritonavir and 3 with cobicistat) and 7/104 controls (7%) had DDIs (6 with itraconazole and 1 with verapamil)"><entity charOffset="78-87" id="DDI-PubMed.31369085.s9.e0" text="ritonavir" /><entity charOffset="152-164" id="DDI-PubMed.31369085.s9.e1" text="itraconazole" /><entity charOffset="176-185" id="DDI-PubMed.31369085.s9.e2" text="verapamil" /><pair ddi="false" e1="DDI-PubMed.31369085.s9.e0" e2="DDI-PubMed.31369085.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31369085.s9.e0" e2="DDI-PubMed.31369085.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31369085.s9.e0" e2="DDI-PubMed.31369085.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31369085.s9.e1" e2="DDI-PubMed.31369085.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31369085.s9.e1" e2="DDI-PubMed.31369085.s9.e2" /></sentence><sentence text=" The main corticosteroid involved was inhaled fluticasone (28/35, 80%) among the cases and oral prednisone (38/104, 37%) among the controls"><entity charOffset="10-24" id="DDI-PubMed.31369085.s10.e0" text="corticosteroid" /><entity charOffset="46-57" id="DDI-PubMed.31369085.s10.e1" text="fluticasone" /><entity charOffset="96-106" id="DDI-PubMed.31369085.s10.e2" text="prednisone" /><pair ddi="false" e1="DDI-PubMed.31369085.s10.e0" e2="DDI-PubMed.31369085.s10.e0" /><pair ddi="false" e1="DDI-PubMed.31369085.s10.e0" e2="DDI-PubMed.31369085.s10.e1" /><pair ddi="false" e1="DDI-PubMed.31369085.s10.e0" e2="DDI-PubMed.31369085.s10.e2" /><pair ddi="false" e1="DDI-PubMed.31369085.s10.e1" e2="DDI-PubMed.31369085.s10.e1" /><pair ddi="false" e1="DDI-PubMed.31369085.s10.e1" e2="DDI-PubMed.31369085.s10.e2" /></sentence><sentence text=" More CS cases (30/35, 86%) than CS controls (62/104, 60%) were serious (OR = 4" /><sentence text="0, 95% CI = 1" /><sentence text="4-14" /><sentence text="4; P = 0" /><sentence text="007)" /><sentence text="" /><sentence text="Antiretroviral-boosting agents were responsible for one out of four iatrogenic CS cases in a French national database" /><sentence text=" Prescribers should be aware of the risk of potentially serious DDIs between antiretroviral-boosting agents and corticosteroids, including single-tablet regimens containing cobicistat"><entity charOffset="112-127" id="DDI-PubMed.31369085.s18.e0" text="corticosteroids" /><entity charOffset="173-183" id="DDI-PubMed.31369085.s18.e1" text="cobicistat" /><pair ddi="false" e1="DDI-PubMed.31369085.s18.e0" e2="DDI-PubMed.31369085.s18.e0" /><pair ddi="false" e1="DDI-PubMed.31369085.s18.e0" e2="DDI-PubMed.31369085.s18.e1" /></sentence><sentence text="" /></document>